Search - tctmd.com

Displaying 1 - 20 of 105

Sort: Relevancy | Date

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

Presentation TVT 2023

What do the New Trials Need to Show In Light of PROTECTED-TAVR

Presenter: Amit Vora

June 09, 2023

Presentation TVT 2023

Novel CEP Devices: Progress in Aortic Arch Deflector Devices

Presenter: Azeem Latib

June 09, 2023

Presentation TVT 2023

Novel New CEP Devices: Progress in Debris Capture and Removal

Presenter: Tamim Nazif

June 09, 2023

Presentation TVT 2023

Position 2: The Trial Was Obviously Negative: Stop Wasting Money!

Presenter: David Cohen

June 09, 2023

Presentation TVT 2023

Has the Dust Settled After PROTECTED TAVR? Flash Review of the Results and What Will We Learn From the BHF-TAVI Study

Presenter: Samir Kapadia

June 09, 2023

Presentation TVT 2023

Stroke after TAVR: To Protect or Not to Protect?

Presenter: John Forrest

June 08, 2023

Presentation TVT 2023

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

Presenter: Tamim Nazif

June 07, 2023

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

Presentation TVT 2022

Pharmacologic "Protection" to Reduce Strokes After TAVR: Current Evidence and Recommendations

Presenter: George Dangas

June 10, 2022

Presentation TVT 2022

LAAO for Atrial Fibrillation After TAVR: The Other Elephant In The Room

Presenter: Amar Krishnaswamy

June 10, 2022

Presentation TVT 2022

Clinical Trial Pathways and Study Designs: Embolic Capture vs Deflection Devices

Presenter: Alexandra Lansky

June 10, 2022

Presentation TVT 2022

Novel Embolic Protection Technologies: The Current State of Play

Presenter: Giora Weisz

June 10, 2022

Presentation TVT 2022

Stroke Prevention With Sentinel: Update From PROTECTED TAVR and BHF PROTECT-TAVI

Presenter: Samir Kapadia

June 10, 2022

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

News Conference News TVT 2022

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Michael O'Riordan

June 09, 2022

Presentation TVT 2022

Percutaneous Debulking of a Mitral Valve Mass in a Patient Presenting with Recurrent Stroke

Presenter: Nahyr Lugo-Fagundo

June 09, 2022

Presentation TVT 2022

Cerebral Embolic Protection and Severity of Stroke Following Transcatheter Aortic Valve Replacement

Presenter: Toshiaki Isogai

June 09, 2022

Presentation TVT 2022

Percutaneous Debulking of a Mitral Valve Mass in a Patient Presenting With Recurrent Stroke

Presenter: Nahyr Lugo-Fagundo

June 09, 2022

News Conference News TVT 2021

New-Generation Watchman FLX Maintains Good Results Through 2 Years

Todd Neale

July 28, 2021

Advertisement

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

What do the New Trials Need to Show In Light of PROTECTED-TAVR

Novel CEP Devices: Progress in Aortic Arch Deflector Devices

Novel New CEP Devices: Progress in Debris Capture and Removal

Position 2: The Trial Was Obviously Negative: Stop Wasting Money!

Has the Dust Settled After PROTECTED TAVR? Flash Review of the Results and What Will We Learn From the BHF-TAVI Study

Stroke after TAVR: To Protect or Not to Protect?

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Pharmacologic "Protection" to Reduce Strokes After TAVR: Current Evidence and Recommendations

LAAO for Atrial Fibrillation After TAVR: The Other Elephant In The Room

Clinical Trial Pathways and Study Designs: Embolic Capture vs Deflection Devices

Novel Embolic Protection Technologies: The Current State of Play

Stroke Prevention With Sentinel: Update From PROTECTED TAVR and BHF PROTECT-TAVI

More Support for Single Antiplatelet Therapy After TAVI

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Percutaneous Debulking of a Mitral Valve Mass in a Patient Presenting with Recurrent Stroke

Cerebral Embolic Protection and Severity of Stroke Following Transcatheter Aortic Valve Replacement

Percutaneous Debulking of a Mitral Valve Mass in a Patient Presenting With Recurrent Stroke

New-Generation Watchman FLX Maintains Good Results Through 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content